Transparency guidelines for the relationship between company activities and medical institutions, etc.
Ominedo Pharmaceutical Industry Co., Ltd. (hereinafter called “the Company”) established the “Transparency guidelines for the relationship between company activities and medical institutions, etc.” as follows in order to ensure the transparency of relationships with medical institutions, etc. in all stages from research and development of medical medicines to the manufacture and sales of products and to obtain a broad understanding that our company’s activities are conducted upon securing high ethical standards.
1. Method and timing of disclosure
The Company will disclose via the Company website the funding that is to be disclosed
for the target year (October to September) after the settlement is finalized.
2. Target for disclosure
The details are listed in each guidance.
◆Ethical medicines
・Click here for the details of Transparency guidelines (ethical medicines)
・Viewing public information (Display the terms of use)
◆OTC medicines
・Click here for the details of Transparency guidelines (OTC medicines)
・Viewing public information (Display the terms of use)
